Viz HDS

by Viz.ai  · Based in United States → — The proven AI-powered care coordination platform
Neurology Neurosurgery Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Viz HDS, also known as Viz ICH+ and Viz Volume Plus, is an AI-powered solution developed by Viz.ai for the analysis of non-contrast CT images. It is designed to automatically label, visualize, and quantify segmentable brain structures, specifically focusing on intracranial hyperdensities, lateral ventricles, and midline shift. This tool aids physicians in the rapid assessment and management of conditions such as intracranial hemorrhage by providing automated volume calculations and color-coded overlays. It integrates seamlessly into existing clinical workflows by sending results in DICOM format back to PACS and is part of the broader Viz. The user’s note mentioned ‘physician directory’ for Viz HDS; however, all available information indicates that Viz HDS/Viz ICH+ is a medical imaging AI tool and not a physician directory service.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered detection and quantification of intracranial hyperdensities
  • Measurement and segmentation of hyperdense collections on non-contrast CT images
  • Color-coded overlays for efficient decision-making
  • Automated total volume calculation for selected collections
  • Displays left and right ventricular volumes and midline shift
  • Results sent in DICOM format back to PACS for seamless integration
  • Real-time alerts and intelligent care coordination
  • Available on mobile and desktop devices
  • Integration with EHR and PACS systems
  • Supports AHA 'Get With the Guidelines' standards for ICH care

Use Cases

  • Accelerating diagnosis and treatment decisions for intracranial hemorrhage (ICH)
  • Streamlining interhospital transfer (IHT) for ICH patients
  • Improving workflow for radiologists, neurologists, and neurosurgeons
  • Assessing severity, monitoring progression, and planning treatment strategies for brain bleeds
  • Automating ICH scoring and documentation
  • Enhancing multidisciplinary care team collaboration

What Physicians Need to Know

Large Vessel Occlusion Detection
Viz Neuro Suite includes Large Vessel Occlusion (LVO) detection.
CT Perfusion (CTP)
Viz Neuro Suite includes CT Perfusion (CTP) analysis.
Hemorrhage Detection
Viz Neuro Suite includes Hemorrhage detection and Hyperdensity Measurements.
Cerebral Aneurysm Detection
Viz Neuro Suite includes Cerebral Aneurysm detection.
Post Acute Stroke
Viz Neuro Suite addresses Post Acute Stroke care.
Triage Prioritization Speed
The platform delivers real-time insights and automated assessments to accelerate diagnosis, streamline workflows, and support faster treatment decisions. It auto-detects suspected diseases across a wide range of therapeutic areas in seconds.
Mobile Notification System
Real-time communications get connected within seconds of suspected disease–wherever and without delay on a mobile or desktop device. One customer states, 'Viz.ai alerts my team to potential LVOs in our network and allows me to quickly view them on my phone.'
Physician Tip

The Viz.ai platform, with over 50 FDA-cleared AI algorithms, is designed to accelerate diagnosis and treatment decisions by providing real-time insights from medical imaging data. Physicians can leverage the Viz Neuro Suite for rapid detection of conditions like Large Vessel Occlusion, Cerebral Aneurysm, and Hemorrhage, as well as for CT Perfusion analysis and Post Acute Stroke care. The mobile notification system ensures that critical alerts and imaging can be accessed quickly on the go, facilitating faster team activation and improved patient access to life-saving treatments. The system aims to significantly save time and improve patient outcomes through AI-powered care coordination.

The Viz.ai platform is described as an 'all-in-one solution' and is equipped with dedicated 24/7 on-call clinical specialists, implementation experts, and a customer success team to assist with integration and support. Viz.ai also mentions pilot programs with Microsoft Cloud for Healthcare.

Details

Category Neurology AI
Pricing Contact for pricing
Mobile App1
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2024-02-05K232363 510(k)Viz HDS

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Viz HDS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Viz HDS.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Viz HDS, which is part of the Viz Neuro Suite, assists with conditions such as Cerebral Aneurysm, CT Perfusion (CTP), Hemorrhage Hyperdensity Measurements, Large Vessel Occlusion (LVO), and Post Acute Stroke.
Viz HDS uses AI algorithms to analyze medical imaging data, such as CT scans, to auto-detect suspected neurovascular diseases, deliver real-time insights, and provide automated assessments to accelerate diagnosis and streamline workflows.
Viz.ai states that its platform features more than 50 advanced, FDA-cleared AI algorithms, indicating compliance with regulatory standards for its AI-powered solutions.
The provided text does not mention specific alternatives to Viz HDS. It focuses solely on the features and capabilities of the Viz.ai platform.
The provided text highlights the benefits and capabilities of Viz HDS but does not explicitly detail any limitations of the system in neurological applications.
Viz HDS is designed to streamline workflows by providing real-time insights and automated assessments, aiming to accelerate diagnosis and support faster treatment decisions for neurovascular diseases.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from Viz.ai

Viz AAA
Viz.ai
Cardiology AI
ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination.
Viz ANEURYSM
Viz.ai
Neurology AI
ai that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management.
Viz CTP
Viz.ai
Clinical Decision Support & Reference
Viz.
Viz HCM
Viz.ai
Cardiology AI
ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-19 | First Added: 2026-04-21

Investors who backed Viz HDS

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.